Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1969 Mar 1;1(5643):545–547. doi: 10.1136/bmj.1.5643.545

Trimethoprim in the Treatment of Urinary Infections in Hospital

R N Grüneberg, R Kolbe
PMCID: PMC1982262  PMID: 4974510

Abstract

Success in the cure of urinary infections of hospital patients was compared for five-day courses of sulphamethoxazole alone, sulphamethoxazole plus one-tenth its weight of trimethoprim, and sulphamethoxazole plus one-fifth its weight of trimethoprim (Septrin). The cure rates were 65%, 84%, and 92% respectively. Fifty-four per cent. of 111 patients had urinary tract abnormalities. Forty-three per cent. of the causative organisms were sulphonamide-resistant in vitro. There were no major side-effects, though two patients had pruritus or a rash.

The degree of potentiation of sulphamethoxazole activity by one-fifth the weight of trimethoprim was so great that its cure rate of infections due to sulphonamide-resistant organisms exceeded that of sulphamethoxazole alone used in infections due to sulphonamide-sensitive organisms. The degree of synergism between trimethoprim and sulphamethoxazole demonstrated in vitro against urinary organisms was directly related to the cure rate of the combination.

Full text

PDF
547

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bushby S. R., Hitchings G. H. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968 May;33(1):72–90. doi: 10.1111/j.1476-5381.1968.tb00475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Darrell J. H., Garrod L. P., Waterworth P. M. Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968 Mar;21(2):202–209. doi: 10.1136/jcp.21.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Grüneberg R. N., Brumfitt W. Single-dose treatment of acute urinary tract infection: a controlled trial. Br Med J. 1967 Sep 9;3(5566):649–651. doi: 10.1136/bmj.3.5566.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ROTH B., FALCO E. A., HITCHINGS G. H., BUSHBY S. R. 5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO. J Med Pharm Chem. 1962 Nov;91:1103–1123. doi: 10.1021/jm01241a004. [DOI] [PubMed] [Google Scholar]
  5. SCHNEIDER M., SCHWARZENBERG L., CATTAN A., SCHLUMBERGER J. R., AMIEL J. L., MATHE G. ESSAI DE TRAITEMENT DE DIVERSES IN FECTIONS 'A "PROTEUS" PAR LE 2,4-DIAMINO-5-(3,4,5-TRIM'ETHOXYBENZYL) PYRIMIDINE, OU (TRIM'ETHOPRIME) Presse Med. 1965 Mar 27;73:893–894. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES